In vitro induction of carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses

This publication has 48 references indexed in Scilit:

• Adenovirally Transduced Dendritic Cells Induce Bispecific Cytotoxic T Lymphocyte Responses Against Adenovirus and Cytomegalovirus pp65 or Against Adenovirus and Epstein-Barr Virus EBNA3C Protein: A Novel Approach for Immunotherapy
  Human Gene Therapy, 2002
• Longitudinal Follow-up of Cellular and Humoral Immunity Induced by Recombinant Adenovirus-Mediated Gene Therapy in Cancer Patients
  Human Gene Therapy, 2000
• Murine dendritic cells infected with adenovirus vectors show signs of activation
  Gene Therapy, 2000
• Immunomodulation therapy in colorectal carcinoma
  Cancer Treatment Reviews, 2000
• Characterization of Factors Involved in Modulating Persistence of Transgene Expression from Recombinant Adenovirus in the Mouse Lung
  Human Gene Therapy, 1997
• Proliferating dendritic cell progenitors in human blood.
  The Journal of Experimental Medicine, 1994
• MHC class‐I‐restricted auto‐tumor‐specific CD4⁺CD8 ⁻T‐cell clones established from autologous mixed lymphocyte‐tumor‐cell culture (MLTC)
  International Journal of Cancer, 1992
• Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus Vaccine
  JNCI Journal of the National Cancer Institute, 1992
• Overcoming inhibition of antibody responses to a malaria recombinant vaccinia virus caused by prior exposure to wild type virus
  Vaccine, 1991
• Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine
  Journal of General Virology, 1990